Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Trial Identifier: GRC00101
Sponsor: Sanofi Pasteur, a Sanofi Company
Start Date: September 2020
Primary Completion Date: December 2020
Study Completion Date: December 2020
Condition: Healthy Volunteers; Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED STATES, Kentucky Bardstown, Kentucky, UNITED STATES, 40004
UNITED STATES, Utah Salt Lake City, Utah, UNITED STATES, 84121